Proscia: New in Concentriq AP: Smoother Review and Enhanced Performance
recent articles
Ibex: Our AI Algorithm to Aid Pathologists with Accurate and Reproducible HER2 and HER2-low Assessment in Breast Cancer Diagnosis TEL AVIV, Israel, Jan. 24, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer...
PreciseDx study analyzes more than 2,000 patient samples, confirming the technology delivers more accurate, objective, diagnostic data than traditional testing. January 23, 2023 — PreciseDx, a leading innovator in AI-powered,...
Crescendo Health’s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research. Company also raises initial funding from top investors;...
Today, Nature Medicine published groundbreaking Owkin research demonstrating the first-ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data. At Owkin, we are on a journey to...
Epredia: Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program WINSTON-SALEM, N.C.--(BUSINESS WIRE)--PHC Group, a global healthcare company and leader in diagnostics and life sciences, will expand its presence in...
Proscia: Transition to modern digital pathology will improve patient care and enable new research breakthroughs AMSTERDAM and PHILADELPHIA – January 18, 2023 – Proscia®, a leading provider of digital and computational pathology...
